Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/11/2012 | CN101830935B Solanum cathayanum alkaloid extract and preparation method and application thereof |
07/11/2012 | CN101801342B Methods for producing aripiprazole suspension and freeze-dried formulation |
07/11/2012 | CN101791295B Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing frozen powder injection |
07/11/2012 | CN101780279B Application of Toll-link receptor-3 agonist to preparation of medicines for promoting wound healing |
07/11/2012 | CN101775053B Method for extracting amino acid and nucleic acid from shell, hoofs and horns of animal |
07/11/2012 | CN101773471B Mitoxantrone targeting sustained-release long-circulating nanometer liposome and preparation method |
07/11/2012 | CN101735172B Cinepazide monohydrate, crystal forms and preparation method thereof |
07/11/2012 | CN101701218B Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof |
07/11/2012 | CN101693037B Application of flavonoid glycoside compounds in preparation of medicines for treating malaria |
07/11/2012 | CN101669938B Nutrient composition for eliminating exercise-induced fatigue |
07/11/2012 | CN101648867B Crystal form of Pravastatin Na, and preparation method and application thereof |
07/11/2012 | CN101646662B Novel prophylactic and/or therapeutic agent for diabetic neuropathy |
07/11/2012 | CN101643493B Peininine bile acid ester, method for preparing same and application thereof |
07/11/2012 | CN101641360B Piperazine derivatives, preparation process and pharmaceutical use thereof |
07/11/2012 | CN101637481B Prescription of gingkgo leaf soft capsule and preparation method thereof |
07/11/2012 | CN101618126B Analgesic antiphlogistic gel and preparation method thereof |
07/11/2012 | CN101596165B Pantoprazole sodium enteric-coated pellet |
07/11/2012 | CN101583597B Sulfonamide derivatives as liver carnitine palmitoyl transferase (L-CPT1) |
07/11/2012 | CN101573448B Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
07/11/2012 | CN101570560B Two sterol derivatives, separation and extraction method thereof and application thereof in preventing and treating prostatoplasia diseases |
07/11/2012 | CN101555214B Phenylcyclobutylacylamide derivative as well as optical isomer, preparation method and application thereof |
07/11/2012 | CN101522185B Antidepressant agent |
07/11/2012 | CN101497581B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
07/11/2012 | CN101481356B Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
07/11/2012 | CN101429174B Piperazine derivant with antineoplastic activity |
07/11/2012 | CN101384600B Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol |
07/11/2012 | CN101353344B Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
07/11/2012 | CN101288641B Coenzyme Q10 water dispersion and preparation method thereof |
07/11/2012 | CN101282978B Macrocylic inhibitors of hepatitis c virus |
07/11/2012 | CN101193907B Novel triterpenic acid derivative and external application agent for skin comprising the same |
07/11/2012 | CN101147803B Anti Toll-like receptor 2 antibody inhibiting tumor metastasis use |
07/11/2012 | CN101139345B Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
07/11/2012 | CN101077866B Substituted benzoxazoles antifungal compounds and preparation method thereof |
07/11/2012 | CN101056617B In-situ forming implant for animals |
07/11/2012 | CN101054417B Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor |
07/11/2012 | CN101006065B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
07/11/2012 | CA2727477A1 Stable ready to use injectable paracetamol formulation |
07/10/2012 | US8217189 Chromenone potassium channel blockers and uses thereof |
07/10/2012 | US8217182 Process for producing cyclic N-hydroxy imide compounds |
07/10/2012 | US8217178 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-flouro-1-(2-methoxy-ethyl)-4-trifluorom as an inhibitor of mast cell tryptase |
07/10/2012 | US8217177 Fused heterocyclic derivatives and methods of use |
07/10/2012 | US8217171 Antiviral agents |
07/10/2012 | US8217168 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors |
07/10/2012 | US8217164 Use of a lactose-derived C-glycoside compound as an agent for activating and regulating cutaneous immunity |
07/10/2012 | US8217163 Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas |
07/10/2012 | US8217151 Pasteurisation process for microbial cells and microbial oil |
07/10/2012 | US8217146 Neurotrophic factors and methods of use thereof |
07/10/2012 | US8217137 Fullerene-based amino acids |
07/10/2012 | US8217123 Stabilized polymeric thiol reagents |
07/10/2012 | US8217086 Phenoxy acetic acids as PPAR delta activators |
07/10/2012 | US8217085 Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms |
07/10/2012 | US8217084 Medicinal products incorporating bound organosulfur groups |
07/10/2012 | US8217083 Mesalamine suppository |
07/10/2012 | US8217080 Anti-infective methods and systems for treating pathogen-induced disordered tissues |
07/10/2012 | US8217079 Method for treating Philadelphia-negative myeloproliferative syndromes |
07/10/2012 | US8217078 Treatment of pain with topical diclofenac |
07/10/2012 | US8217077 HMB uses thereof |
07/10/2012 | US8217076 Method for preparing largazole analogs and uses thereof |
07/10/2012 | US8217075 2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them |
07/10/2012 | US8217073 Pyrrole derivatives as therapeutic compounds |
07/10/2012 | US8217072 Fermentation product of marine actinomyces strains; antiproliferative agents; anticarcinogenic agents; low molecular weight, high pharmaceutical potency, and selectivity for cancer cells |
07/10/2012 | US8217071 Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases |
07/10/2012 | US8217070 2-substituted-1H-benzimidazole-4-carboxamides are PARP inhibitors |
07/10/2012 | US8217069 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
07/10/2012 | US8217068 Compound with anesthetics activity, methods for its production and pharmaceutical compositions comprising the same |
07/10/2012 | US8217067 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
07/10/2012 | US8217066 Compounds as lysophosphatidic acid receptor antagonists |
07/10/2012 | US8217065 Organic compounds |
07/10/2012 | US8217064 Tetrasubstituted benzenes |
07/10/2012 | US8217063 Lactam-substituted dicarboxylic acids and use thereof |
07/10/2012 | US8217061 Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof |
07/10/2012 | US8217060 Benzimidazole derivatives useful as TRP M8 receptor modulators |
07/10/2012 | US8217058 Substituted piperidino phenyloxazolidinones |
07/10/2012 | US8217057 Polymorphs of a c-MET/HGFR inhibitor |
07/10/2012 | US8217056 Triazolothiadiazole inhibitor of c-Met protein kinase |
07/10/2012 | US8217055 Pyrido-pyrazine derivatives useful as herbicidal compounds |
07/10/2012 | US8217054 Use of polyols to obtain stable polymorphous forms of rifaximin |
07/10/2012 | US8217053 Camptothecin derivatives with antitumor activity |
07/10/2012 | US8217052 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof |
07/10/2012 | US8217051 Spiroindolinone derivatives |
07/10/2012 | US8217050 Adenine derivative as inhibitors of HSP90 for the treatment of cancer |
07/10/2012 | US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
07/10/2012 | US8217047 Therapeutic methods and compounds |
07/10/2012 | US8217046 Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists |
07/10/2012 | US8217045 Organic compounds |
07/10/2012 | US8217044 Spiroindolinone pyrrolidines |
07/10/2012 | US8217043 Compounds and methods for their use |
07/10/2012 | US8217042 Pyridopyrazines and their use as modulators of kinases |
07/10/2012 | US8217041 Indene derivatives, their preparation and use as medicaments |
07/10/2012 | US8217040 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
07/10/2012 | US8217039 Aprepitant polymorph mixtures |
07/10/2012 | US8217038 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
07/10/2012 | US8217037 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers |
07/10/2012 | US8217036 Triazine compounds as PI3 kinase and mTOR inhibitors |
07/10/2012 | US8217035 Pyrimidine derivatives used as PI-3-kinase inhibitors |
07/10/2012 | US8217034 Chemical compounds |
07/10/2012 | US8217033 Methods and compositions for the delivery of a therapeutic agent |
07/10/2012 | US8217032 Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
07/10/2012 | US8217031 Heteroaryl derivatives |
07/10/2012 | US8217030 Association of a sinus node if current inhibitor and a beta blocker |